Abstract
BackgroundInterstitial lung disease (ILD) is the leading cause of death in systemic sclerosis (SSc). According to expert statements, not all SSc-ILD patients require pharmacological therapy.ObjectivesTo describe disease characteristics and disease...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have